ContraMed today announced the publication of the results of a prospective, randomized clinical evaluation of VeraCept compared to a standard copper IUD. The paper, “A randomized comparison of a novel nitinol fame low-dose copper intrauterine contraceptive and a copper T380S intrauterine contraceptive” reports primary and secondary comparative outcomes over 24 months of use.
Published online at the journal Contraception.